US02079K1079 - Common Stock
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 257.637B 41.15% | 282.836B 9.78% | 307.394B 8.68% | 352.582B 14.70% | ||||||||
EBITDA YoY % growth | 91.155B 65.97% | 90.77B -0.42% | 100.172B 10.36% | 142.586B 42.34% | N/A | |||||||
EBIT YoY % growth | 78.714B 90.94% | 74.842B -4.92% | 88.226B 17.88% | 102.73B 16.44% | ||||||||
Operating Margin | 30.55% | 26.46% | 28.70% | 29.14% | ||||||||
EPS YoY % growth | 5.61 91.19% | 4.55 -18.90% | 5.80 27.44% | 7.01 20.95% | N/A | N/A |
All data in USD
Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 1.73 20.10% | ||||||||||
Revenue Q2Q % growth | 85.341B 14.39% | ||||||||||
EBITDA Q2Q % growth | 35.773B | N/A | N/A | N/A | N/A | ||||||
EBIT Q2Q % growth | 25.41B 15.99% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 1.89 61.54% | 1.56 | 0.33 | 21.17% |
Q4 2023 Q2Q % growth | 1.64 56.19% | 1.64 | 0.00 | -0.02% |
Q3 2023 Q2Q % growth | 1.55 46.23% | 1.49 | 0.06 | 3.73% |
Q2 2023 Q2Q % growth | 1.44 19.01% | 1.38 | 0.06 | 4.44% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 80.539B 15.41% | 80.95B | -411M | -0.51% |
Q4 2023 Q2Q % growth | 86.31B 13.49% | 87.892B | -1.582B | -1.80% |
Q3 2023 Q2Q % growth | 76.693B 11.00% | 78.25B | -1.557B | -1.99% |
Q2 2023 Q2Q % growth | 74.604B 7.06% | 75.002B | -398M | -0.53% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | -0.12% | 0.49% | 0% | 1.98% |
Revenue | 0.04% | -0.07% | 0% | 0.5% |